Nature of the M2 Muscarinic Receptor Signaling Complex Revealed by Dual-Color FCS and FRET  by Li, Yuchong et al.
Sunday, February 16, 2014 101aIn order to investigate the molecular mechanism by which ligands control the
degree of activation of the metabotropic glutamate receptor (mGluR), a class C
G-protein Coupled Receptor (GPCR), we monitored the kinetics of the confor-
mational re-orientation that occurs within the extracellular ligand-binding
domain, and which has been shown mandatory for G-protein activation. Using
single molecule Fo¨rster Resonance Energy Transfer, we demonstrate that the
receptor continuously oscillates between a resting- and an active- state on a
sub-millisecond timescale, and that the role of ligands is exclusively to influ-
ence the transition rates between them, in agreement with the conformational
selection theory. In addition, this study reveals that the mechanism of action
of partial agonists is to finely tune the transition rates between these extreme
states, rather than stabilizing a static alternative conformation. Altogether,
these results represent a most-valuable contribution to the better understanding
of the activation mechanism of mGluRs, and possibly GPCRs in general, and
might contribute to facilitate the characterization of new potential drugs.
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Deregulation of the epidermal growth factor receptor (EGFR) signalling has
been correlated with the development of a variety of human carcinomas. Re-
ceptor dimerization and phosphorylation are amongst the earliest events in
signal transduction. Binding of EGF is thought to induce a conformational
change which unfolds an ectodomain loop required for dimerization. It may
also induce important allosteric changes in the cytoplasmic domain. Despite
these findings, ensemble-averaging methods could not resolve the details of re-
ceptor activation in situ. Here, we used two-color single-molecule imaging to
study the effect of ATP-competitive small molecule tyrosine kinase inhibitors
(TKI) and phosphatase-based manipulation of EGFR phosphorylation on live
cells. Ligand bound receptors were tracked on the plasma membrane with a so-
phisticated Bayesian segmentation tracking algorithm and the distribution of
dimer lifetimes was fitted to a single-exponential to extract dimer off-rates
(koff). Our data show that, pre-treatment with type I TKI, gefitinib (active
conformation binder) stabilizes the EGFR homodimer. Over-expression of
EGFR specific DEP-1 phosphatase was also found to have a stabilizing effect
on the homodimer. When a nonactivating anti-EGFR antibody, Snap-425 sin-
gle-chain variable fragment that competes for EGF binding was used as a
ligand, no significant difference in the koff of the dimer could be detected.
Conformational changes of the cytoplasmic part of the receptor upon gefitinib
pre-treatment were also confirmed by changes in Fluorescence Resonance En-
ergy Transfer (FRET) efficiency detected by ensemble FRET/FLIM (Fluores-
cence Lifetime Intensity Microscopy). These results provide direct evidence
that receptor phosphorylation is linked to dimer stability. The phosphorylated
and non-phosphorylated receptors exhibit different kinetics and cytoplasmic
conformations which may account for the heterogeneity in ligand-binding af-
finity observed through a concave-up Scatchard plot.
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Lateral diffusion enables efficient interactions between membrane proteins
leading to the transmission of chemical signals within and across the plasma
membrane. An open question in this context is how central cell surface recep-
tors are distributed over space and time and thereby influence the transmem-
brane signaling network. Here we study the mobility of a prototypical G
protein coupled receptor, the neurokinin 1 receptor (NK1R) during its
different phases of cellular signaling. The investigation of thousands of single
NK1R trajectories reveals a very characteristic mobility distribution pattern
with two major receptor populations, one showing high mobility and low
lateral restriction, the other low mobility and high restriction. The mobility
distribution pattern changes in a characteristic manner upon (i) agonist activa-
tion, (ii) receptor desensitization, (iii) receptor endocytosis, and (iv) receptor
recycling. The study uncovers the functional role of the heterogeneous spatio-
temporal distribution of individual GPCRs during the entire cellular signalling
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G-protein coupled receptors (GPCRs) are important cell signaling membrane
proteins that have been targeted by ~30-40% of marketed drugs for treating
many human diseases including cancer and heart failure. The X-ray crystal
structure of the M2 muscarinic receptor, a key GPCR that regulates human
heart rate and contractile forces of cardiomyocytes, was determined in an inac-
tive antagonist-bound state. Through accelerated molecular dynamics (aMD)
enhanced sampling simulation, we captured activation of the M2 receptor
that occurs on the millisecond timescales(1). The receptor activation is charac-
terized by large-scale structural rearrangements of the transmembrane helices
via an intermediate state. With activation-associated conformers of the M2 re-
ceptor revealed from aMD simulation, a fragment-based site mapping program
FTMAP is applied to explore the receptor surface. Seven allosteric sites are
identified with two distributed in the solvent-exposed extracellular and intracel-
lular mouth regions and five in the lipid-exposed pockets formed by transmem-
brane helices of the receptor(2). Virtual screening is then performed to select
small-molecule drugs that bind these allosteric sites with differential affinity
and thus stabilize the receptor in the corresponding conformational states. In
contrast to highly conserved residues in the orthosteric site where endogenous
ligands bind, residues in the allosteric sites exhibit large diversity across
different GPCR subtypes. Therefore, ligands that bind GPCR allosteric sites
are able to provide potential receptor-selective therapeutics.
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The mechanism of signaling via G protein-coupled receptors (GPCRs) remains
unresolved, and two questions have been the focus of much attention and
debate: namely, the oligomeric status of the receptor, and the nature of its inter-
action with the G protein. Here, we examine those questions with the M2
muscarinic receptor using a combination of dual-color fluorescence spectros-
copy (dcFCS) and Fo¨rster resonance energy transfer (FRET). The unambiguous
identification of a complex afforded by cross-correlation in dcFCS allows
recruitment to be distinguished from conformational effects as the basis of
changes in FRET. Both FRET and dcFCS were measured using a spectrally
well-separated pair of fluorescent proteins, eGFP and mCherry (mCh), which
were fused at the N- or the C-termini of the receptor and at position 91 of
the ai1-subunit of Gi1. Insertion of the fluorophore in ai1 did not disrupt func-
tion, as measured by ligand-induced changes in the fluorescence of Trp 211 in
switch region II. Oligomers of the receptor (eGFP-M2 and mCh-M2) and of the
G protein (eGFP-ai1b1g2 and mCh-ai1b1g2) were identified at the membrane of
live CHO cells. In the absence of an agonist, there is neither FRET nor cross-
correlation between receptor and G protein (M2-mCh and eGFP-ai1b1g2). Acti-
vation of the receptor by carbachol leads to a rapid increase in FRET and the
appearance of cross-correlation, which suggests that G proteins bind only to
activated receptors. Cross-correlation also revealed oligomers of the G protein
(eGFP-ai1b1g2 and mCh-ai1b1g2) in solution which persisted after the addition
of AlF4
. Taken together, our data suggest that an agonist promotes the tran-
sient interaction of an oligomer of receptors with an oligomer of heterotrimeric
G proteins.
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The Ga subunit of heterotirmeric G Proteins is responsible for regulating intra-
cellular signals through guanine nucleotide binding and release, the catalytic
rate limiting step. Recent studies have shown interactions of Ga with Guanine
